Literature DB >> 17091403

Effects of glucose, insulin, and supernatant from pancreatic beta-cells on brain-pancreas relative protein in rat hippocampus.

Yan-Hua Lin1, Christel Westenbroek, Lu Tie, Ai-Hua Liu, He-Ming Yu, Gert J Ter Horst, Xue-Jun Li.   

Abstract

Brain-pancreas relative protein (BPRP) is a novel protein that mainly expresses in brain and pancreas. In our previous study, we found that various stressors significantly decreased the expression of BPRP in pancreas in vivo, accompanied by changes in insulin and glucose levels, and that expression of BPRP in pancreas also decreased significantly in diabetic rats induced by Streptozocin (STZ). All these findings suggest that BPRP may be a glucose or insulin-sensitive protein. However, how the changes in insulin or glucose levels influence the expression of BPRP in hippocampus requires further study. Here, we investigated the effects of insulin or glucose on the expression of BPRP in primary cultured hippocampal neurons. We supplied hippocampal neurons with glucose, insulin, or supernatant from pancreatic beta-cells, which secrete insulin into the supernatant. Our data showed that insulin had beneficial effect on the viability while no significant effect on the expression of BPRP in hippocampal neurons. On the contrary, 40 mM glucose or free glucose culture significantly decreased the expression of BPRP, while had no significant effect on the viability and apoptosis of hippocampal neurons. Further study showed that levels of insulin in the supernatant collected from pancreatic beta-cells medium changed over days, and that supernatant increased the viability of hippocampal neurons, while it had no obvious effect on the expression of BPRP in hippocampal neurons. These results suggest that BPRP may be a glucose-sensitive protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17091403     DOI: 10.1007/s11064-006-9193-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  38 in total

Review 1.  Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects.

Authors:  J W Unger; J N Livingston; A M Moss
Journal:  Prog Neurobiol       Date:  1991       Impact factor: 11.685

2.  Relationship between plasma and cerebrospinal fluid insulin levels of dogs.

Authors:  S C Woods; D Porte
Journal:  Am J Physiol       Date:  1977-10

3.  Evidence for an insulin-sensitive receptor in the central nervous system.

Authors:  O Szabo; A J Szabo
Journal:  Am J Physiol       Date:  1972-12

4.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

Review 5.  Hypoglycemic brain damage.

Authors:  Roland N Auer
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

6.  Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers.

Authors:  C P Moxham; V Duronio; S Jacobs
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

7.  Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells.

Authors:  E Recio-Pinto; F F Lang; D N Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Hypothalamic changes in diabetic Chinese hamsters. A semiquantitative, light and electron microscopic study.

Authors:  G Bestetti; G L Rossi
Journal:  Lab Invest       Date:  1982-12       Impact factor: 5.662

9.  Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage.

Authors:  Puneet Singh; Anu Jain; Gurcharan Kaur
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

10.  Cerebral lesions in rats with streptozotocin-induced diabetes.

Authors:  N Mukai; S Hori; M Pomeroy
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.